Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6406)
All Articles published online
|
Publishing Process of This Article
|
Jan 26, 2015 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Stem Cells
ISSN
1948-0210
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Saltarella I, Lamanuzzi A, Reale A, Vacca A, Ria R. Identify multiple myeloma stem cells: Utopia? World J Stem Cells 2015; 7(1): 84-95 [PMID: 25621108 DOI: 10.4252/wjsc.v7.i1.84] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v7/i1/84.htm |
| Number | Citing Articles |
| 1 |
Abbas K. Samadi. Mechanism of the Anticancer Effect of Phytochemicals. The Enzymes 2015; 37: 73 doi: 10.1016/bs.enz.2015.05.002
|
| 2 |
Anastasios Karadimitris, Aristeidis Chaidos, Valentina Caputo, Katerina Goudevenou, Kanagaraju Ponnusamy, Xiaolin Xiao. Myeloma Propagating Cells, Drug Resistance and Relapse. Stem Cells 2015; 33(11): 3205 doi: 10.1002/stem.2199
|
| 3 |
Michele Moschetta, Yawara Kawano, Klaus Podar. Plasma Cell Dyscrasias. Cancer Treatment and Research 2016; 169: 63 doi: 10.1007/978-3-319-40320-5_6
|
| 4 |
Omar S. Al-Odat, Daniel A. Guirguis, Nicole K. Schmalbach, Gabriella Yao, Tulin Budak-Alpdogan, Subash C. Jonnalagadda, Manoj K. Pandey. Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. International Journal of Molecular Sciences 2022; 24(1): 644 doi: 10.3390/ijms24010644
|
| 5 |
Reinaldo Franqui-Machin, Erik B. Wendlandt, Siegfried Janz, Fenghuang Zhan, Guido Tricot. Cancer stem cells are the cause of drug resistance in multiple myeloma: fact or fiction?. Oncotarget 2015; 6(38): 40496 doi: 10.18632/oncotarget.5800
|
| 6 |
Shan Meng, Chenyang Lu, Wanggang Zhang, Wenjun Shen, Yongchang Wei, Dan Su, Fuling Zhou. MMSA-1 expression pattern in multiple myeloma and its clinical significance. Clinical and Experimental Medicine 2016; 16(4): 599 doi: 10.1007/s10238-015-0393-y
|
| 7 |
Minjie Gao, Yuanyuan Kong, Guang Yang, Lu Gao, Jumei Shi. Multiple myeloma cancer stem cells. Oncotarget 2016; 7(23): 35466 doi: 10.18632/oncotarget.8154
|
| 8 |
E. D. Sverdlov, I. P. Chernov. Cancer Stem Complex, Not a Cancer Stem Cell, Is the Driver of Cancer Evolution. Biochemistry (Moscow) 2019; 84(9): 1028 doi: 10.1134/S0006297919090050
|
| 9 |
Sultan Abda Neja. The roles of TRAF3 mutation in the oncogenic progression and drug response of multiple myeloma. Genome Instability & Disease 2020; 1(5): 278 doi: 10.1007/s42764-020-00022-x
|
| 10 |
Amr Mohamed Yehia, Elsayed G.E. Elsakka, Ahmed I. Abulsoud, Nourhan M. Abdelmaksoud, Ahmed Elshafei, Samy Y. Elkhawaga, Ahmed Ismail, Mahmoud Mohamed Mokhtar, Hesham A. El-Mahdy, Maghawry Hegazy, Mohammed S. Elballal, Osama A. Mohammed, Hussein M. El-Husseiny, Heba M. Midan, Walaa A. El-Dakroury, Moataz B. Zewail, Sherif S. Abdel Mageed, Yasser M. Moustafa, Randa M. Mostafa, Mohamed A. Elkady, Ahmed S. Doghish. Decoding the role of miRNAs in multiple myeloma pathogenesis: A focus on signaling pathways. Pathology - Research and Practice 2023; 248: 154715 doi: 10.1016/j.prp.2023.154715
|
| 11 |
Vanessa Pinto, Rui Bergantim, Hugo R. Caires, Hugo Seca, José E. Guimarães, M. Helena Vasconcelos. Multiple Myeloma: Available Therapies and Causes of Drug Resistance. Cancers 2020; 12(2): 407 doi: 10.3390/cancers12020407
|
| 12 |
Antonio Giovanni Solimando, Matteo Claudio Da Vià, Niccolò Bolli, Torsten Steinbrunn. The Route of the Malignant Plasma Cell in Its Survival Niche: Exploring “Multiple Myelomas”. Cancers 2022; 14(13): 3271 doi: 10.3390/cancers14133271
|